Article Includes Bench Tips for Optimizing 3D Cell Culture with Customizable Hydrogels
BioTime Division ESI BIO Launches New Responsive Design Website to the Scientific Community
BioTime Organizes New ESI BIO Division to Develop, Manufacture and Market the Company’s Cell-Based Research Products - Appoints Jeffrey Janus as CEO of ES Cell International Pte Ltd.
BioTime CEO Dr. Michael West to Give Keynote Address at the MSC 2013 Adult Stem Cell Therapy & Regenerative Medicine Conference
BioTime Receives NIH Approval for Four GMP Human Embryonic Stem Cell Lines: ESI-035, ESI-049, ESI-051 and ESI-053 approved for use in federally funded research
Acquisition to Accelerate Development of Research and Therapeutic Products
Tweets by @ESI_BIO
ESI BIO - A Division of BioTime, Inc.1301 Harbor Bay ParkwayAlameda, CA 94502
Privacy | Terms & Conditions
For Research Use Only. Not approved for use in human, therapeutic, or diagnostic applications.
© ESI BIO . Unless otherwise noted, ESI BIO, ESI BIO logo and all other trademarks are the property of BioTime, Inc.